Fig. 5: Sensitivity analysis in patients who received first-line VRd.

Sankey plot showing treatment patterns (A), and Kaplan–Meier curves for TTNT (B) and OS (C). OS overall survival, t translocation, TTNT time to next treatment, VRd bortezomib lenalidomide dexamethasone.